These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 5600114)
41. Diagnostic relevance of humoral and cell-mediated immune reactions in patients with acute viral myocarditis. Maisch B; Trostel-Soeder R; Stechemesser E; Berg PA; Kochsiek K Clin Exp Immunol; 1982 Jun; 48(3):533-45. PubMed ID: 6288291 [TBL] [Abstract][Full Text] [Related]
42. Cardiomyopathy due to Coxsackie B. Frenkel HS J Iowa Med Soc; 1972 Oct; 62(10):527-30. PubMed ID: 5074338 [No Abstract] [Full Text] [Related]
43. [Coxsackie virus infections in the newborn with special reference to encephalomyocarditis]. CREMER HJ Dtsch Med Wochenschr; 1962 Nov; 87():2436-8. PubMed ID: 14023768 [No Abstract] [Full Text] [Related]
46. [Pathological anatomy of encephalomyocarditis caused by Coxsackie viruses in newborn infants]. CHUTKINA AV Zdravookhr Beloruss; 1962 Dec; 8():39-42. PubMed ID: 14021266 [No Abstract] [Full Text] [Related]
47. [Coxsackie virus B4 encephalitis in a young female who developed mental symptoms, and consciousness disturbance, and completely recovered]. Hirayama M; Tokuda A; Mutoh T; Kuriyama M Rinsho Shinkeigaku; 1998 Jan; 38(1):60-2. PubMed ID: 9597914 [TBL] [Abstract][Full Text] [Related]
48. [An experimental study on inhibitory effect of xinjierkang granules on virus myocarditis]. Wang QM; Chen GL; Wang YJ; Wang HS; Gao MH; Gong YZ Zhongguo Zhong Yao Za Zhi; 2000 May; 25(5):293-6. PubMed ID: 12512454 [TBL] [Abstract][Full Text] [Related]
49. [On a case of acute benign Coxsackie B2 myocarditis]. Ricciardiello PT; Stangalini A G Mal Infett Parassit; 1967 Jul; 19(7):409-12. PubMed ID: 5606364 [No Abstract] [Full Text] [Related]
50. High yield production of an inactivated coxsackie B3 adjuvant vaccine with protective effect against experimental myocarditis. Fohlman J; Pauksen K; Morein B; Bjare U; Ilbäck NG; Friman G Scand J Infect Dis Suppl; 1993; 88():103-8. PubMed ID: 8390713 [TBL] [Abstract][Full Text] [Related]
51. [Neuropathies caused by Coxsackie virus]. Bertrand A; Janbon F Cah Coll Med Hop Paris; 1967; 8(9):769-77. PubMed ID: 5619601 [No Abstract] [Full Text] [Related]
52. [Histopathological observation of experimental slight viral myocarditis]. Cheng J; Chen YC; Hu BJ; Zhang Y; Zeng JL; Liu Y Fa Yi Xue Za Zhi; 2001 Feb; 17(1):4-6, 61. PubMed ID: 12533881 [TBL] [Abstract][Full Text] [Related]
53. Effects of naloxone, an opiate receptor antagonist, on coxsackievirus B3 myocarditis in the mouse. Kishimoto C; Takada H; Hiraoka Y; Shiraki K Cardiovasc Res; 1995 Jan; 29(1):80-4. PubMed ID: 7895243 [TBL] [Abstract][Full Text] [Related]
54. Virus receptor trap neutralizes coxsackievirus in experimental murine viral myocarditis. Lim BK; Choi JH; Nam JH; Gil CO; Shin JO; Yun SH; Kim DK; Jeon ES Cardiovasc Res; 2006 Aug; 71(3):517-26. PubMed ID: 16806133 [TBL] [Abstract][Full Text] [Related]
55. Fatal myocarditis associated with Coxsackie by B3 infection in the newborn. TUUTERI L; LAPINLEIMU K; MEURMAN L Ann Paediatr Fenn; 1963; 9():56-64. PubMed ID: 13994980 [No Abstract] [Full Text] [Related]
56. [Cardiovascular function in Coxsackie disease in adults]. Bogomolov BP; Mol'kova TN Ter Arkh; 1988; 60(11):40-3. PubMed ID: 3238575 [TBL] [Abstract][Full Text] [Related]